Abstract
Purpose
We aim to study certain histopathological characteristics of the retinoblastoma (RB) tumors in globes with clinically advanced RB, which can be correlated with the high-risk features including: tumor differentiation, growth pattern and focality. We also aim to reclassify the tumor pathologically in the analyzed cases according to the American Joint Committee on Cancer (AJCC) 8th edition in an attempt to compare the validity of this newest classification.
Methods
Retrospective study of patients diagnosed with clinical RB of groups D and E during the period: January 2013 to December 2017 at King Khaled Eye Specialist Hospital (KKESH) and King Abdulaziz University Hospital (KAUH). Charts were reviewed for demographic and basic clinical data. Histopathological features (tumor differentiation, growth pattern, focality, seeding, and presence of choroidal invasion (focal versus massive), level of optic nerve (ON) invasion, anterior chamber invasion, scleral and extra-scleral extension, and finally the documented pathological tumors (pT) classification based on the AJCC 7th edition were collected.
Results
We included 146 eyes with advanced retinoblastoma (groups D and E) from 104 patients. Gender distribution was almost equal with 54 males. Median age was 12 months (range 1–96 months), and a mean age was 17.1 ± 15.1 months. No family history was found in the majority (94.2%). Clinically, the most common presenting symptoms: leukocoria (73.3%), squint (33.6%) and least commonly proptosis (2.7%). A total of 106 enucleation specimens were reviewed. Degree of RB differentiation was: well differentiated (18%), moderate (30%), poor (35%), and undifferentiated (17%). The most common high-risk features were ON invasion (68%) with the majority being prelaminar in nature, choroidal invasion (45%) with more than half being massive, iris/trabecular meshwork (TM)/Schlemm's canal invasion (8.5%), and then intra-scleral/extra-scleral extension (5%). Less tumor differentiation doubles the relative risk of massive choroidal invasion (with 95% CI) with a statistically significant P value (P = 0.030). Endophytic RB was associated with vitreous seeding, while exophytic tumors were associated with subretinal seeding (P = 0.001) each. Ten cases with combined ON invasion (pre-laminar) and focal choroidal invasion were reclassified pT2a in the AJCC 8th edition instead of pT2b in the older 7th edition.
Conclusions
Our demographic and basic clinical data for advanced RB are comparable to other similar reports. The tumor growth pattern correlates well with the type of seeding observed in enucleated globes with RB. Less tumor differentiation is a relative risk of massive choroidal invasion. It is advocated to implement the AJCC 8th edition by ocular pathologists worldwide aiming to histopathologically classify the RB tumor in cases for selective adjuvant chemotherapy.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Kaliki S, Mittal P, Mohan S, Chattannavar G, Jajapuram SD, Mohamed A, Palkonda VAR (2019) Bilateral advanced (group D or E) intraocular retinoblastoma: outcomes in 72 Asian Indian patients. Eye (Lond) 33(8):1297–1304. https://doi.org/10.1038/s41433-019-0409-z
MacCarthy A, Birch JM, Draper GJ et al (2009) Retinoblastoma in great britain 1963–2002. Br J Ophthalmol 93:33–37. https://doi.org/10.1136/bjo.2008.139618
Zhao J, Dimaras H, Massey C, Xu X, Huang D, Li B, Chan HS, Gallie BL (2011) Pre-enucleation chemotherapy for eyes severely affected by retinoblastoma masks risk of tumor extension and increases death from metastasis. J Clin Oncol 29:845–851
Shields CL, Mashayekhi A, Demirci H, Meadows AT, Shields JA (2004) Practical approach to management of retinoblastoma. Arch Ophthalmol 122(5):729–735
Shields CL, Shields JA (2006) Basic understanding of current classification and management of retinoblastoma. Curr Opin Ophthalmol 17(3):228–234
Shields CL, Mashayekhi A, Au AK, Czyz C, Leahey A, Meadows AT, Shields JA (2006) The international classification of retinoblastoma predicts chemoreduction success. Ophthalmology 113(12):2276–2280
Kashyap S, Sethi S, Meel R, Pushker N, Sen S, Bajaj MS, Chandra M, Ghose S (2012) A histopathologic analysis of eyes primarily enucleated for advanced intraocular retinoblastoma from a developing country. Arch Pathol Lab Med 136:190–193
Wilson MW, Qaddoumi I, Billups C, Haik BG, Rodriguez- GC (2011) A clinic-pathological correlation of 67 eyes primarily enucleated for advanced intraocular retinoblastoma. Br J Ophthalmol 95:553–558
Tamboli A, Podgor MJ, Horm JW (1990) The incidence of retinoblastoma in the United States: 1974 through 1985. Arch Ophthalmol (Chicago, Ill 1960) 108:128–132
Gurney JG, Severson RK, Davis S et al (1995) Incidence of cancer in children in the United States. Sex-, race-, and 1-year age-specific rates by histologic type. Cancer 75:2186–2195
Wong JR, Tucker MA, Kleinerman RA, Devesa SS (2014) Retinoblastoma incidence patterns in the US surveillance, epidemiology, and end results program. JAMA Ophthalmol 132(4):478–483. https://doi.org/10.1001/jamaophthalmol.2013.8001
Fernandes AG, Pollock BD, Rabito FA (2018) Retinoblastoma in the United States: a 40-year incidence and survival analysis. J Pediatr Ophthalmol Strabismus 55(3):182–188
Kaliki S, Maniar A, Patel A, Pakonda AR, Mohamed A (2019) Clinical presentation and outcome of retinoblastoma based on age at presentation: a review of 1450 children. Int Ophthalmol. https://doi.org/10.1007/s10792-019-01155-z
Abramson DH, Frank CM, Susman M (1998) Whalen MP, Dunkel IJ, Boyd NW 3rd. Presenting signs of retinoblastoma. J Pediatr 132:505–508
Smith SJ, Pulido JS, Salomão DR, Smith BD, Mohney B (2012) Combined intravitreal and subconjunctival carboplatin for retinoblastoma with vitreous seeds. Br J Ophthalmol 96:1073–1077
Palazzi M, Abramson DH, Ellsworth RM (1990) Endophytic vs exophytic unilateral retinoblastoma: is there any real difference? J Pediatr Ophthalmol Strabismus 27(5):255–258
Al Kofide A, Al-Sharif E (2019) Chapter: Retinoblastoma management: advances in chemotherapy. In: Alkatan HM (ed) Retinoblastoma, past, present and future. ISBN 978-1-78984-791-8. https://www.intechopen.com/books/retinoblastoma-past-present-and-future
Acknowledgements
The authors would like to thank Ms. Priscilla W. Gikandi (MPH), Research Unit, Department of Ophthalmology, College of Medicine, King Saud University for, her extensive help with the data management and analysis.
Funding
This work did not receive funding from any of the institutions.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflict of interest or financial disclosures in relation to this work.
Ethical approval
This study was prepared in accordance with the ethical standards of the human ethics committee at KKESH and expedited approval as a retrospective study from the HEC/IRB of the Research department in accordance with the Helsinki Declaration (Research project # RP 1941-R).
Informed consent
A general informed written consent was taken from the guardians of all cases which includes permission for anonymous use of data and photographs and reporting for the purpose of publication.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Alkatan, H.M., AlQahtani, F.S. & Maktabi, A.M. Enucleated globes with advanced retinoblastoma: correlation of histopathological features and reclassification of tumors according to the 8th edition of the American Joint Committee on Cancer (AJCC). Int Ophthalmol 40, 1739–1747 (2020). https://doi.org/10.1007/s10792-020-01342-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10792-020-01342-3